In the present study, we focused on the production of the chemokine CXCL1, also termed KC, by cultured Theiler murine encephalomyelitis virus (TMEV)-infected mouse astrocytes. cRNA from mock-and TMEV-infected cells was hybridized to the Affymetrix murine genome U74v2 DNA microarray. Hybridization data analysis demonstrated upregulation of two sequences coding for IL-8 and related to the GRO 1 oncogene MGSA. The murine counterpart of the above human genes has been reported to be the chemokine CXCL1 or KC, and therefore we studied its regulation, confirming its mRNA increase by Northern blots. The presence of CXCL1 in the supernatants of infected cells was further demonstrated by a specific ELISA and its intracellular accumulation by flow cytometry. This secreted CXCL1 was biologically active in a non species-specific way as it induces chemoattraction on human neutrophils and monocyte/macrophages, but not on CD3 positive lymphocytes. Its induction does not follow the MAP kinase pathway which transcripts are decrease in infected cells compared with uninfected astrocytes. Two inflammatory cytokines, IL-1α and TNF-α, which are also induced by TMEV in astrocytes, were potent inducers of CXCL1. Nevertheless, both mechanisms of induction follow different pathways as antibodies to both cytokines fail to inhibit TMEV-induced CXCL1 upregulation. Spinal cords but not brains from TMEV-infected SJL/J animals contain CXCL1 at the start of clinical signs of the disease. As no CXCL1 induction can be detected neither in cultured BALB/c astrocytes nor in nervous tissue, we propose an important role for CXCL1 in this experimental model of multiple sclerosis as a chemoattractant of destructive immune cells.
Introduction
Chemotactic cytokines or chemokines are a family of small proteins that cause leukocyte migration. Based on the relative position of its cysteine residues, chemokines have been classified in four subfamilies. CXCL1 (KC) is a mouse chemokine belonging to the CXC (C = cystein) mouse chemokine family, or α family, of this immunoregulatory cytokines (Schall, 1994) . The gene coding for CXCL1 is the murine homologue of a human oncogene termed GRO, coding for a "melanome growth-stimulating activity" that was originally induced in quiescent fibroblasts by platelet-derived growth factor and bombesin (Cochran et al., 1983; Oquendo et al., 1989; Ryseck et al., 1989) . It codes for a secretory protein of 8 kDa that is mainly induced by LPS in macrophages and vascular cells (Lira et al., 1994) . The primary sequence of CXCL1 protein shares 63% identity to the mouse inflammatory protein-2 (MIP-2), another member of the CXC mouse chemokine family (Oquendo et al., 1989) . Both exert its activity through a unique mouse receptor (Heinrich and Bravo, 1995) that shows a 68 and 71% amino acid identity to human IL-8Rα and IL-8Rβ, respectively (Lee et al., 1995) . Therefore, CXCL1 has been proposed as a functional homologue of human IL-8 and is associated with neutrophil recruitment and inflammation. Influx of neutrophils from the blood and its interaction with vascular endothelium at the site of infection or damage is an early step of acute inflammation (Godiska et al., 1995) .
Theiler's murine encephalomyelitis virus (TMEV) is a picornavirus that persistently infects the murine central nervous system (CNS) (Theiler, 1937) . After intracerebral inoculation of the BeAn low-neurovirulence strain, susceptible strains of mice develop a chronic demyelinating disease that is reminiscent of human multiple sclerosis (MS) (Clatch et al., 1986; Gerety et al., 1994) . Myelin breakdown is mediated by the immune system rather than being a direct consequence of viral infection of oligodendrocytes, the myelin forming cell (Clatch et al., 1986; Lipton and Dal Canto, 1976; Peña Rossi et al., 1991; Roos et al., 1982) . Focal inflammation occurs in the white matter of the brain and spinal cord, and mononuclear immune cell infiltrates were observed in demyelinating areas (Clatch et al., 1986) . Therefore, chemokines, charged with recruitment and influx of immune cells, can be involved in this process and one of them, the CXCL1 chemokine, was analyzed in the experiments reported in the present article. To determine if genes coding for chemokines are upregulated in response to infection by TMEV in astrocytes, the main glial population in the CNS, we have used cDNA microarray hybridization technology to perform a large-scale examination of gene expression. This technology has been useful in the study of several gene expression patterns. Microarray analysis of gene expression in SJL/J astrocytic cells identifies a variety of genes whose mRNA patterns change in response to Theiler's virus infection, but do not change in sham-infected cells.
Chemokines have been associated with the trafficking of immune cells in connection with inflammatory cell recruitment in different diseases, including neuroinflammatory diseases as MS (Asensio and Campbell, 1999) . The rationale of this article is based on the demonstrated fact that astrocytes are an early component of the immune response to TMEV and the demonstration of CXCL1 production by astrocytes from TMEV-susceptible SJL/J but not for the resistant BALB/c mouse strains. This suggests a crucial role for this glial population in TMEV-induced demyelination.
Results

TMEV-induced alterations in gene expression
The Affymetrix GeneChip SE437 and SE438 microarray mouse gene expression analysis reveals that two sequences with a PFAM (Protein FAMilies) database hit description as "IL-8" have the UniGene title of "GRO 1 oncogene" and the SCOP (Structural Classification Of Proteins) description of "melanoma growth-stimulating activity" (Table 1) . Those sequences were not expressed in sham-infected astrocytes and exhibit a fold change of 14.8 and 13.8, respectively, in infected cells. Both were located in mouse chromosome number 5 and had a GO (Gene Ontology) database cellular component notation indicating that both are extracellular and involved in chemotaxis and inflammatory response. The GRO oncogene codes for a factor named "melanoma growth-stimulating activity" or MGSA, and it has been demonstrated as being the human homologue of the gene coding for the mouse chemokine CXCL1 (Oquendo et al., 1989) . Therefore, our DNA array gene expression analysis indicates an overexpression of the CXCL1 chemokine that was further validated and investigated in this article.
TMEV-induced expression of CXCL1 mRNA in astrocytes
In order to study the effect of TMEV infection on CXCL1 mRNA expression, cultured SJL/J astrocytes were infected at different m.o.i. for 24 h, and total RNA was purified and analyzed by Northern blots. CXCL1 mRNA levels increased in a dose-responsive manner, peaking at a m.o.i. of 10. Transcripts above background could be detected down to a m.o.i. of 1 (Fig. 1, upper panel) . The system seems saturated at a m.o.i. of 10 as further increases did not augment the levels of transcription (not shown). When the relative amount of mRNA was quantified with a Model 300 A computing densitometer (Molecular Dynamics Inc., Sevenoaks, Kent, UK), it was shown that the bands obtained after infection at m.o.i. of 1 and 10 were 8 and 20 times more dense as compared to the background. The probing of BALB/c astrocytes infected in the same conditions was consistently found negative (not shown).
ELISA and flow cytometry detection of CXCL1
Culture supernatants of SJL/J brain astrocytes infected in vitro at different m.o.i.s showed high CXCL1 production, as determined by using the Quantikine R M mouse KC ELISA kit ( Fig. 2A) . Supernatants from mock-infected cultures (0), from cultures infected at an m.o.i. of 0.1 or with UV light-inactivated BeAn virus failed to show any significant CXCL1 activity. Maximal CXCL1 levels were detected using an m.o.i. of 10. When we explored the kinetics of CXCL1 production for periods ranging from 4 to 48 h, we detected maximal release to the supernatant after 48 h (Fig. 2B) . Astrocytes from BALB/c mice, a strain resistant to TMEV demyelination, produce almost undetectable levels of CXCL1 when infected in the same Table 1 UniGene and SCOP described as "GRO 1 oncogene" or "melanoma growth-stimulating activity" (MGSA) upregulated sequences in the TMEV-induced expression of the IL-8 family genes in astrocytes conditions as SJL/J astrocytes (the minimum detectable dose of the kit is 2.0 pg/ml). To rule out that the BALB/c strain is a poor producer of CXCL1, we stimulated cultures of peritoneal exudate cells as a source of macrophages (10 6 cells per culture) with 1 μg/ ml of LPS for 48 h. BALB/c cells produced similar levels of CXCL1 to those produced by SJL/J peritoneal cell cultures (around 60 ng/ml in cultures of both inbred strains). BALB/c astrocytes are susceptible to infection in the same extent as SJL/J, both producing titers of around 5-30 × 10 5 PFU/ml, as determined by titration of supernatants on BHK-21 cells (Rubio et al., 2003) .
As shown in Fig. 2C , flow cytometry also demonstrated that intracellular accumulation of CXCL1 rises from negative control levels in uninfected astrocytes (thin line histogram) to positive staining in TMEV-infected cells (black filled histogram). BALB/c astrocytes show negative staining either in mock-or TMEV-infected cells, in accordance with ELISA results from Figs. 2A and B (not shown).
Chemotaxis and effect of anti-CXCL1 antibodies MIP-2-containing astrocyte supernatants from cultures infected with TMEV attract mouse neutrophils and monocytes (Rubio et al., 2006) . The members of the CXC chemokine family show no species specificity, being active on cells from other species. In order to stress that our TMEV-induced demyelination acts as an experimental model for human multiple sclerosis, in this article, we have analyzed whether those supernatants also had a chemotactic activity on human buffy coat cells. Supernatants from astrocytes containing around 1000 pg/ml of CXCL1 according with the ELISA measurements were chosen for those chemotactic experiments. Undiluted supernatant had a clear chemotactic activity on human cells (Fig. 3, 0) . The positive control was provided by the chemokine stromal cell-derived factor 1α (SDF-1α), a potent chemoattractant routinely used as a control in chemotaxis (Fig. 3, SDF) . This chemokine attracts several cell types, mainly T lymphocytes (Sanz-Rodriguez et al., 2001) . We used it to demonstrate that our supernatants chemoattract other cell populations different from T-cells, majority in the buffy coat cell population (see Fig. 4 ). The supernatants of SJL/J mockinfected astrocytes as well as of BALB/c infected astrocytes had no chemoattractant effect on any cell population (not shown). We next tried to inhibit the action of CXCL1 using neutralizing antibodies in order to determine the possible contribution of other redundant chemokines to the observed chemotactic activity. Antibodies against CXCL1 inhibit chemotaxis (Fig.  3 ), but around 40% of the activity, measured as number of migrating cells, cannot be inhibited by increasing amounts of antibodies going up to 60 μg/ml. Therefore, this activity is attributed to other chemokines, including MIP-2, present in the supernatants.
Antigenic characterization of the chemoattracted cell populations
We further studied the phenotypic characteristics of the chemoattracted cell populations using the flow cytometer (Fig. 4) . The SDF-1α chemoattracted population (A population) is composed of 76.4% of T lymphocytes stained by anti-CD3 antibodies. Concerning the two cell populations chemoattracted by TMEV-infected SJL/J astrocyte supernatants (B and C), both populations were stained at 93% by anti-CD11b antibodies, one commonly used antibody to detect neutrophils and monocyte/macrophages (Sabroe et al., 2002) . The C population cells were stained by the neutrophil-specific CD66B antibodies (56.2%) as well as the B population cells (8%). Hence, we assume that B population is composed of 8% neutrophils and of 85% (93-8) monocyte/macrophages. C population, having of a fewer number of cells, is therefore composed of 56% neutrophils and 37% (93-56) monocyte/macrophages (Fig. 4) .
CXCL1 induction by inflammatory cytokines
Four recombinant inflammatory cytokines (IL-1α, IL-6, IFN-γ and TNF-α) were tested for their possible role in the upregulation of CXCL1 in SJL/J astrocytes. As shown in Fig.  5A , neither IL-6 nor IFN-γ upregulated chemokine production by astrocytes. Conversely, IL-1α and TNF-α (at a concentration of 10 ng/ml) increased the release of CXCL1 to the cultures supernatants to levels of 20 and 7 ng/ml respectively. To determine the minimal dose of cytokines required for CXCL1 induction, astrocytes were incubated with 1, 10 and 100 ng/ml, showing that CXCL1 was readily detected after stimulation with 1 ng/ml of both IL-1α and TNF-α, whereas IL-6 and IFN-γ were always found negative (not shown). The ELISA used (Quantikine R M mouse KC assay) has no significant crossreactivity with any of the four inflammatory cytokines studied here. As both IL-1α and TNF-α may be an important stimulus for CXCL1 autocrine expression in vitro, we tested neutralizing antibodies against both cytokines on TMEV-induced upregulation (Figs. 5B and C). A very weak reduction of the levels of CXCL1 chemokine in the supernatants either at 48 or 24 h after infection was detected, even at concentrations of 100 μg/ml of both neutralizing antibodies in the culture medium. We obtained the same negative results when both antibodies were added together to the cultures (not shown). Therefore, both chemokine and cytokine induction by TMEV seems to follow independent pathways.
MAP kinase inhibition
Several viruses trigger activation of the mitogen-activated proteins (MAP) kinase phosphorylation pathway, which is involved in the control of host cell proliferation and survival. Based on the reported role of the MAP kinase pathway in mediating human IL-8 production, MAP/ERK kinase inhibitor PD98059 was added to astrocyte cultures before TMEV infection at concentrations that block IL-8 synthesis. As shown in Fig. 6 , the inhibitor did not reduce CXCL1 production in a significant way even at PD98059 concentrations of 100 μM, when it induces 88% inhibition of IL-8 production in human T cells at a concentration of 12.5 μM (Harris et al., 2002) . In order to check if MAP/ERK-related transcripts were changed in TMEV-infected astrocytes, we studied the transcripts with a SCOP database description of MAP kinases, in the data analysis provided by the DNA array hybridization results. As a matter of fact, the SCOP family "d.144.1.1:MAP kinase Erk2" includes seven transcripts that are clearly decreased and only one that is increased (Table 2 ). This means that TMEV induces in astrocytes a decrease of overall MAP kinase activity that agreed with the results from Fig. 6 and that the induction of CXCL1 is not mediated by the MAP/ERK kinase pathway. The Fig. 3 . Migration induced by TMEV-infected undiluted mouse astrocyte supernatant (0) and the effect of neutralizing antibodies against the CXCL1 chemokine on chemotaxis of human buffy coat cells. Different amounts of antibody (3, 30 and 60 μg) were studied for its capacity to inhibit migration. The number of chemoattracted cells was determined by flow cytometry. The positive migration control was induced by SDF-1α (SDF) at a concentration of 100 ng/ml and (−) was the unspecific migration of the cells towards culture medium in the lower compartment of the transwell chamber. Data represent the mean ± SD of triplicate samples. *Significant differences with the unspecific migration control group were determined by the Student's t test (P < 0.01).
inhibitor did not affect the ability of TMEV to replicate as cells produced a normal amount of 22 ± 5 × 10 5 PFU/ml at 100 μM PD98059 concentration, compared with 21 ± 7 × 10 5 PFU/ml in the absence of inhibitor. Neither cell viability was affected at the higher concentration of inhibitor used, as determined by 0.4% Trypan blue staining (not shown).
Intracranial TMEV infection induces CXCL1 in SJL/J mice
We investigated the pathological relevance of our findings in this experimental model of multiple sclerosis, measuring the levels of CXCL1 in SJL/J and BALB/c mice using 10% homogenates of brains and spinal cords from animals infected intracerebrally with the BeAn strain of TMEV. All brain homogenates were consistently found negative in the ELISA test but a significant peak (P < 0.01) of CXCL1 in spinal cord (800-900 pg/ml) was detected by days 11-13 after TMEV injection, decreasing thereafter to negative background levels (Fig. 7) . This time corresponds to the start of clinical signs of demyelination, particularly the chronic gait abnormality and spasticity (Lipton, 1975 , Clatch et al.,1986 . It also corresponds to the expression of several chemokines mRNAs in SJL/J spinal cords, detected by RT-PCR (Hoffman et al., 1999) . All nervous tissues from untreated or TMEV-injected BALB/c mice were consistently found negative.
Discussion
Astrocytes play an important role in the immune response that triggers demyelination after intracerebral infection by the TMEV low-neurovirulence BeAn viral strain. This demyelinating process is currently used as an experimental model for MS. It has been proposed that cytokines and chemokines released in the site of TMEV infection lead to recruitment and accumulation of virus-specific CD4+ T cells, monocyte/macrophages, neutrophils and other immune cells in the CNS. Those cells would cause demyelination by a nonspecific bystander response resulting in stripping of myelin lamellae (Clatch et al., 1986) .
Using hybridization to the U74v2 DNA microchip array from Affymetrix, we demonstrated the overexpression of genes homologous to the human IL-8 family in murine astrocytes infected with the BeAn virus. Despite the possible presence of other chemokines in those supernatants, we focused on the most prominent member of the CXC mouse chemokine family, the CXCL1 or KC chemokine, quantifying and characterizing its chemoattractant biological activity. Our GeneChip microarray analysis demonstrates the upregulation of other chemokines as MIG (CXCL9), with a mean fold increase of 13.0, IP-10 (CXCL10) (fold increase of 10.4) and MIP-2 (CXCL2) (fold increase of 10.2). The 14.3-fold increase in expression of CXCL1 is therefore somewhat higher than that found for the above chemokines.
Two genes coding for a melanome growth-stimulating activity or GRO 1 were overexpressed after TMEV infection (Table 1) , and the CXCL1 gene is the murine homologue of this human gene (Oquendo et al.,1989) . The Gene Ontology notation indicated that the products of those genes were extracellular and, as a matter of fact, the CXCL1 chemokine is released to the culture medium by infected astrocytes and can be detected and quantified by a specific ELISA. CXCL1 released to tissue culture supernatants is also biologically active in a non-species-specific way as it attracts human buffy coat neutrophils and monocyte/macrophages, but not CD3 + T lymphocytes. This fact stresses the usefulness of our experimental model for human MS. CXCL1 induction is independent Fig. 5 . Induction of CXCL1 in astrocytes by inflammatory cytokines. In panel A, astrocytic cultures were untreated (−) or treated with 10 ng/ml each of recombinant IL-1α, IL-6, IFN-γ and TNF-α for 48 h. Supernatants were then centrifuged and tested for the presence of CXCL1 by ELISA. In panels B and C, astrocytes in 6-well multiwell plates were infected with TMEV at an m.o.i. of 10 for 1 h at room temperature, washed and then incubated for either 24 or 48 h in medium containing different amounts of anti-IL-1α or anti-TNF-α purified neutralizing antibodies. Supernatants were further tested for CXCL1 by ELISA. Data represent the mean ± SD of triplicate samples. Significant differences with the untreated control groups as determined by the Student's t test (P < 0.01) * or (P < 0.05) **. of the MAP kinases pathway as it is not inhibited by the MAP/ ERK-kinase specific inhibitor PD98059. mRNA specific for CXCL1 has been demonstrated in TMEVinfected astrocytes, validating the DNA microarray hybridization results (Fig. 1) . Our DNA hybridization results are consistent with previous reports of the detection of increases in several chemokine mRNAs, including those coding for IP-10, by RNase protection or RT-PCR assays in TMEV-infected astrocytes Kim, 2001, 2004) . The presence of several chemokines in the CNS of the experimental autoimmune encephalomyelitis (EAE) mice, another T-cell-mediated model for MS, as well as in the brain of patients affected by MS itself, has been recently reviewed (Bajetto et al., 2002) .
We also report the induction of CXCL1 expression by astrocytes treated by cytokines usually involved in immune mediated inflammatory processes, including IL-1α and TNF-α, but not by others as IL-6 and IFN-γ (Beutler and Cerami, 1987; Dinarello., 1989; Kishimoto, 1989) . Previously published results from our laboratory report that BeAn virus induces TNF-α and IL-1α in SJL/J astrocytes, but not in BALB/c astrocytes (Rubio and Capa, 1993; Sierra and Rubio, 1993) . The peak of TNF-α release to the culture medium was reported to be reached after 24 h (Sierra and Rubio, 1993) and that of IL-1α after 12 h (Rubio and Capa, 1993) . As maximal CXCL1 production is detected 48 h post-infection (Fig. 2) , the induction of the two cytokines precedes the overexpression of the chemokine, suggesting some overlapping. In our hands, neutralizing antibodies against IL-1α and TNF-α fail to reduce TMEV-induced CXCL1 production (Figs. 5B and C), indicating that in this model the induction of chemokines and cytokines follows distinct temporal patterns and pathways. Conversely, the injection of anti-IL-1α antibodies intradermally in mice after surgical injury has been reported to block the production of CXCL1 and MIP-2 by 50% (Wiekowski et al., 2001 ). Another various stimuli have been demonstrated to induce CXCL1 chemokine gene expression as surgical injury in vivo (Endlich et al., 2002) or treatment of dendritic cells with other chemokine as RANTES (CCL5) (Fischer et al., 2001) .
Multiple unlinked genes are actually involved in mouse strain susceptibility to TMEV-induced demyelination. So far, one is located in the H-2D region (Clatch et al., 1985) and others map in chromosomes 3, 6 and 11 (Melvold et al., 1987; Melvold et al., 1990; Aubagnac et al., 1999) . According with our Gene Chip analysis, overexpressed CXCL1 genes were located in mouse chromosome number 5 (Table 1) . Nevertheless, we propose that CXCL1 produced intracranially by astrocytes is one of the chemokines used for the recruitment and influx of neutrophils and monocyte/macrophages inside the CNS after TMEV infection. Those phagocytic cell types migrate to inflamed sites during the immune response and possess a battery of enzymes that can damage myelin.
Interestingly, we have detected CXCL1 in the spinal cord of the susceptible SJL/J, but not in resistant TMEV-infected BALB/c strains, during the acute phase of the disease due to encephalitis (Fig. 7) . The chemokine could be produced, in addition to other cell types of the CNS, by astrocytes of the gray and white matter of the spinal cord that also contains abundant virus detected by immunohistochemical methods from 7 to 10 days onward after infection (Dal Canto and Lipton, 1982) . The fact that CXCL1 expression was detected in spinal cord but not in brain homogenates must be explained by the fact that BeAn virus replication peak in the brain on day 5 and decline 1000-fold by days 11 to 13 post-infection. This decrease is accompanied by increase of 50-to 100-fold (P < 0.005) in viral RNA copy numbers in spinal cords starting on day 11, as determined by real-time RT-PCR (Trottier et al., 2004) . The same authors detect the presence of the chemokine RANTES (CCL5) in brain tissue that decreases to low levels after 7-9 days post-infection (Trottier et al., 2004) .
Therefore, a direct implication of CXCL1 in the chemoattraction of destructive neutrophils and monocyte/ macrophages that form, in addition to T cells, the characteristic infiltrates in areas of demyelination is proposed. CD3 positive encephalitogenic T lymphocytes could be chemoattracted by other chemokines, mainly RANTES (CCL5) and IP-10 (CXCL10), also found in the CNS during the TMEVinduced disease. Transgenic models have been developed in mice for the study of upregulation of CXCL1 in several tissues (Lira et al., 1994) or specifically in the lung (Tsai et al., 1998) and the CNS (Tani et al., 1996) . In this case, a remarkable infiltration of neutrophils in the brain was demonstrated followed by a neurological syndrome of postural instability and spasticity (Tani et al., 1996) . Those models confirm the in vivo chemoattractant properties of CXCL1 for neutrophils and other polymorphonuclear cells. The presence of CXCL1 in the spinal cords of TMEVsusceptible but its absence in TMEV-resistant strains of mice during the acute phase of the disease could correlate with the influx of immune cells into the CNS, which can induce a bystander response resulting in myelin breakdown. The novelty of the strain-dependent expression of CXCL1 both 6 PFU of TMEV. The 10% homogenates were tested in the CXCL1 ELISA test, and results represented corrected to 100% values. Data represent the mean ± SD of three individual samples. *Significant differences with the untreated control groups as determined by the Student's t test (P < 0.01).
in vivo and in vitro reported by us is therefore the central focus of interest in this article. Very recently, it was reported that CXCL1 is specifically upregulated in astrocytes from active MS lesions (Omari et al., 2005) . Our findings produce some insights into the regulation of immune cell trafficking in inflammatory conditions in the CNS and identify potential therapeutic targets by limiting cell infiltration in MS.
Materials and methods
Astrocyte cultures
Astrocyte cultures were prepared by mechanical dissociation of the cerebral cortex from newborn SJL/J and BALB/c Cum mice (Rubio et al., 2003) . The cortex was isolated under a dissecting microscope and cleaned of choroid plexus and meninges. Cell suspensions were filtered through 135-μm pore size mesh into Dulbecco's modified Eagle medium (DMEM) containing 10% fetal calf serum (FCS) and penicillin-streptomycin (Gibco BRL, Paisley, Scotland). After centrifugation, cells were filtered through a 40 μm nylon cell strainer (Falcon-Becton Dickinson, Le Pont De Claix, France) and cultured in 75-cm 2 tissue culture flasks (Costar, Cambridge, MA) at 37°C. The medium was changed after 4 days in culture and subsequently 2 times a week for the entire culture period. Cultures were enriched for astrocytes by the removal of less adherent microglia and oligodendrocytes by shaking overnight at 37°C at 250 rpm in a table top shaker (Thermo Forma, Marietta, OH). Cellular confluence was observed 10 days after plating, producing around 1 × 10 7 cells per flask and showing a polygonal flat morphology. A mean of 98% astrocytes was confirmed by indirect immunofluorescence staining of methanol-fixed cultures using rabbit anti-glial fibrillar acidic protein (GFAP) antiserum (Dakopatts, Glostrup, Denmark). The lack of noticeable mature oligodendrocytes or microglial/macrophage cells was determined using a guinea pig anti-myelin basic protein (MBP) antiserum prepared as described elsewhere (Rubio and Cuesta, 1989) and monoclonal anti-Mac-1 antibody (Serotec, Oxford, UK). Secondary fluorescein-labeled antibodies were purchased from Sigma Chemical Co (St. Louis, MO).
Viruses and infection
For these studies, a strain of TMEV isolated in 1957 from a feral mouse in Belem, Brazil, called BeAn 8386, was used. Baby hamster kidney cells (BHK-21) were grown at 37°C in DMEM containing 10% FCS and penicillin-streptomycin. BHK-21 cell cultures were infected for 48 h at 33°C, sonicated and centrifuged in the cold to remove cells debris. Virus titer (10 8 plaque-forming units (PFU)/ml) was determined by a standard plaque assay on BHK-21 cells with 1% Noble agar (Difco Laboratories, Detroit, MI) and staining with 0.2% crystal violet in 20% methanol. Purified astrocytes in 75-cm 2 tissue culture flasks were infected with BeAn virus at several multiplicities of infection (m.o.i.) in a volume of 10 ml of DMEM containing 0.1% BSA, at room temperature for 1 h. After infection, cells were washed, 10 ml of DMEM plus 10% FCS was added and flasks were incubated at 37°C for different periods of time. No changes in cell viability, as determined by 0.4% Trypan blue (Gibco BRL) uptake, nor cytopathic effect or loss of normal morphology under the microscope were detected after infection with BeAn virus, although the percentage of infected cells is almost 100% (Zheng et al., 2001) . Cells used for mock infections were incubated with a virus-free BHK-21 cell lysate. For UV lightvirus inactivation, viral samples were irradiated at 560 μW/ cm 2 for 15 min. These conditions produced inactivated virus stocks devoid of infectious virus, as determined by plaque assay (< 10 PFU/ml).
cRNA target preparation and hybridization
Three different SJL/J astrocyte cultures infected at an m.o.i. of 10 were harvested 24 h post-infection, washed with phosphate-buffered saline and total RNA was isolated by using the TRIzol reagent (Gibco BRL) followed by a further purification with RNeasy Mini Kit (Qiagen, Valencia, CA). Ten micrograms of RNA was converted to cDNA by using the kit SuperScript Choice System (Gibco BRL). Secondstrand synthesis was performed using T4 DNA polymerase, and cDNA was isolated by phenol-chloroform extraction. Isolated cDNA was transcribed using the BioArray High Yield RNA transcript Labeling Kit (Enzo Biochem, New York, NY) with biotin-labeled UTP and CTP to produce biotin-labeled cRNA. Labeled cRNA was isolated using the RNeasy Mini Kit and fragmented in 100 mM potassium acetate-30 mM magnesium acetate-40 mM Tris-acetate (pH 8.1) for 30 min at 94°C. Hybridization performance was analyzed using Test 2 arrays (Affymetrix, Santa Clara, CA) and spike and housekeeping controls. Target cRNA was hybridized to the murine genome U74v2 microarray (Affymetrix) according to manufacturer's protocols. Briefly, 15 μg of fragmented cRNA was hybridized for 16 h at 45°C with constant rotation (60 rpm). The microarrays were washed and stained with streptavidin-conjugated phycoerythrin (SAPE) using the Affymetrix GeneChip Fluidic Station 400. All hybridization steps were performed by Medplant Genetics Inc. (Barakaldo, Spain).
Data analysis
Each gene on the U74v2 array is represented by 20 different 25-base cDNA oligonucleotides complementary to a cRNA target transcript (perfect match). As a hybridization specificity control, an oligonucleotide containing a single base substitution corresponding to each perfect-match cDNA oligonucleotide (mismatch) is represented on the array. The combination of perfect-match and mismatch cDNA oligonucleotides for each gene is termed a probe set. By using Affymetrix-defined absolute mathematical algorithms describing perfect-match and mismatch intensities, each gene was defined as absent or present and assigned a value. Binding intensity values were scaled to evaluate differential expression following TMEV virus infection. Based on Affymetrix-defined comparison mathematical algorithms, a virusinduced transcript was classified as unchanged, marginally increased, marginally decreased, increased or decreased. The changes were quantified by the signal log ratio corresponding to the log 2 of the fold change for each gene. Standard errors in mean transcriptional expression of a gene were also calculated.
Northern blot analysis
Confluent monolayers of purified astrocytes were infected with TMEV as previously stated. Total RNA was purified using the RNeasy Mini Purification kit (Qiagen). Ten micrograms per lane was electrophoresed on a formaldehyde-agarose gel and transferred to nylon membranes (ZetaProbe, Bio-Rad Laboratories, Hercules, CA) and probed in Rapid-hyb buffer (Amersham Biosciences). The probe used was the 25-base oligonucleotide 5′-cacagctttcccgtggactttcctt-3′ specific for mouse CXCL1 mRNA (NCBI accession number S79767; base numbers 801-825) synthesized by SigmaGenosys Ltd. (Cambridgshire, UK). The probe was labeled with (γ-32 P)ATP (Amersham Biosciences) using Ready-ToGo T4 polynucleotide kinase (Amersham Pharmacia Biotech). Unincorporated radiolabel was removed on Micro-Spin G-50 columns (Amersham Pharmacia Biotech). Blots were exposed to Kodak X-OMAT film with an intensifying screen at − 80°C. Hybridization to a human β-actin probe (Clontech, Palo Alto, CA) served as an internal control for loading. The probe was labeled with ( 32 P)dCTP using the random-primed method (Boehringer Mannheim, Germany). Unincorporated radiolabel was removed on S-300 Micro-Spin columns.
Chemokine assay CXCL1 concentrations in cell culture supernatants and mouse CNS were determined using the Quantiquine R M mouse KC ELISA immunoassay (R&D Systems, Minneapolis, MN). This kit has a sensitivity of 2 pg/ml with no significant cross-reactivity with MIP-2 or other mouse chemokines observed. For flow cytometric analysis of intracellular CXCL1 staining, mock-and TMEV-infected (m.o.i. of 10, 48 h infection) astrocyte cultures were detached from the flasks with Versene (Gibco BRL) and cell membranes permeabilized with 0.3% Saponin (Sigma) in PBS-1% FCS, for 5 min at room temperature. Cells were washed one time by centrifugation with PBS-1% FCS, 0.2% sodium azide (Sigma) and 0.1% Saponin and incubated with anti-KC goat IgG antibodies (R&D Systems). After two washes, cells were incubated with the secondary FITCconjugated rabbit anti-goat antibody (Sigma) diluted 1:200, in the same conditions as above. After three more washes, cells were fixed in 1% paraformaldehyde and analyzed in a FACSCalibur flow cytometer (Becton Dickinson Biosciences, Palo Alto, CA). Data from 10,000 cells were collected and evaluated using the CellQuest 3.1f software supplied with the instrument.
Migration assay and FACS cell characterization
Venous blood from healthy adult volunteers was collected into EDTA-containing tubes. Circulating cells were isolated by Ficoll density centrifugation (Pharmacia Biotech, Uppsala, Sweden) and washed twice in medium to remove residual EDTA. Cell viability was assessed by Trypan blue exclusion and was invariably >98%. Chemotactic assays were conducted in the upper chamber of transwell chambers (3-μm pore size membrane) (Costar, Cambridge, MA). Briefly, each upper chamber was loaded with 25,000 cells in a total volume of 500 μl of DMEM plus 0.5% BSA medium (600 μl). Different dilutions of TMEV-infected astrocyte cultures medium were added to the lower chamber and transwells were incubated at 37°C in a 5% CO 2 atmosphere for 3 h. Cells were collected from the bottom compartment, centrifuged, resuspended and quantified using a flow cytometer (Coulter EPICS-XL). The positive controls contained in the lower chamber 100 ng/ml stromal cell-derived factor-1α (SDF-1α) (Calbiochem, La Jolla, CA) and the negative controls DMEM plus 0.5% BSA medium. Cell characterization was assessed by flow cytometry using (1) anti-CD3 antibody for T lymphocyte, (2) anti-CD11b antibody for neutrophil-monocyte/macrophages and (3) anti-CD66b for granulocyte-neutrophil staining. An irrelevant P3X63 mAb was used for negative control staining. All antibodies were from BD Biosciences-Pharmingen, San Diego, CA. In the chemokine neutralization experiments, 1-ml aliquots of supernatants were incubated with different amounts of purified anti-KC goat IgG antibodies (R&D Systems) for 1 h at 37°C followed by 2 h at 4°C and then tested in the migration assay.
MAP kinase inhibitor and proinflammatory cytokines treatments
Astrocyte cultures were pretreated with 1-100 μM of the mitogen-activated protein (MAP)/extracellular signaling kinase (ERK)-specific inhibitor PD98059 (New England Biolabs, Beverly, MA) for 2 h at 37°C, washed and infected with TMEV as previously stated. In another series of experiments, cells were treated for 48 h with 10 ng/ml of the following mouse recombinant proinflammatory cytokines: mouse recombinant IL-1α (Genzyme, Cambridge, MA); rIFN-γ of murine origin (Holland Biotechnology, Leiden, The Netherlands); recombinant murine tumor necrosis factor-α (TNF-α) (Innogenetics, Antwerp, Belgium); and rIL-6 (Boehringer Mannheim, Germany). To test antibodies against IL-1α and TNFα, astrocytes were trypsinized from 75 cm 2 flasks to 6-well multiwell plates (Costar) and infected for 1 h at room temperature with TMEV at an m.o.i. of 10. After washing, the cultures were incubated for 24 or 48 h in 2 ml of complete medium per well, containing 1, 10 or 100 μg of the IgG fraction of goat antiserum against mouse IL-1α or goat affinity isolated antibodies anti-TNF-α, both from Sigma. After this periods of time, centrifugated supernatants were tested for the presence of CXCL1 by ELISA.
Intracerebral inoculations of mice
Six-week-old SJL/J and BALB/c mice were purchased from The Jackson Laboratory, Bar Harbor, ME and maintained on standard feed and water ad libitum at the Instituto Cajal. Mice were anesthetized with fluorthane and injections made using a 25-μl Hamilton syringe in the right cerebral hemisphere. Twenty microliters of a suspension of BeAn virus (2 × 10
